WTN News Blogs FusionCIO Fusion CEO-CIO Symposium Digital Healthcare Conference WTN Media Advertise

Home Page Subscribe Calendar Columns IT Biotech Health Tech Economy Capital CIOs Visions More Topics…

Reproduction permitted for personal use only. For reprints and reprint permission, contact reprints@wistechnology.com.

Stemina Biomarker receives $150,000 SBIR grant

WTN News

May 30, 2008

Madison, Wis. - Stemina Biomarker Discovery, a Madison-based company co-founded by stem cell scientist Garbriella Cezar, will receive a $150,000 Phase I grant from the National Cancer Institute through the federal government's Small Business Innovation Research grant program.

The grant will be used to develop a test that could combine stem cell research and metabolomics to determine whether cancer-fighting drugs kill cancerous stem cells, which otherwise can regenerate. Metabolomics is the systematic study of biomarkers that specific cellular processes leave behind.

Stemina is using human embryonic stem cells for “biomarker” research, including whether new drug candidates cause birth defects in humans.

The company was co-founded in 2006 by Cezar, a University of Wisconsin-Madison scientist who is using stem cells to study autism, and by chief executive officer Beth Donley, a former general counsel for the Wisconsin Alumni Research Foundation and former executive director of the WiCell Research Institute.

In addition to the National Cancer Institute grant, Stemina has raised $1.5 million from angel investors and has received a $1 million start-up grant from the state of Wisconsin.

Comments

Kathy Szabelski responded 1 year ago: #1

My name is Kathy Szabelski and have a 9 year old boy with a diagnosis on the Autism Spectrum. I saw an article in the 6/16/08 Forbes magazine referencing the stem cell research. The end of the article refers to Autism. I would like more information on the Autism part of the research. It is an epidemic and I am interested in any ideas of explanation, treatment and/or cure. I watch my son struggle every day and will for the rest of his life as do many other parents. If you and direct me to additional information with respect to your research, I would love the reading.

Add Your Comment

Comment Policy: WTN News accepts comments that are on-topic and do not contain advertisements, profanity or personal attacks. Comments represent the views of the individuals who post them and do not necessarily represent the views of WTN Media or our partners, advertisers, or sources. Comments are moderated and not immediately posted. Your email address will not be posted.

WTN Media cannot accept liability for the content of comments posted here or verify their accuracy. If you believe this comment section is being abused, contact edit@wistechnology.com.